Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The metabolism of L-3-O-methyldopa, a precursor of dopa in man.

× No keyword cloud information.

18 in total

1. Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson's disease.

Authors: Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal: J Pharmacokinet Pharmacodyn Date: 2005-08 Impact factor: 2.745

Review 2. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1971 Impact factor: 9.546

3. Demethylation of L-3-methoxytyrosine in vivo.

Authors: G Bartholini; A Pletscher
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1972 Impact factor: 3.000

4. The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations.

Authors: R J Hardie; S L Malcolm; A J Lees; G M Stern; J G Allen
Journal: Br J Clin Pharmacol Date: 1986-10 Impact factor: 4.335

Review 5. Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors: J M Cedarbaum
Journal: Clin Pharmacokinet Date: 1987-09 Impact factor: 6.447

6. Systemic activity of orally administered L-dopa in the elderly Parkinson patient.

Authors: M A Evans; E J Triggs; G A Broe; N Saines
Journal: Eur J Clin Pharmacol Date: 1980 Impact factor: 2.953

7. The role of 3-O-methyldopa in the side effects of L-dopa.

Authors: Eun-Sook Y Lee; Hongtao Chen; Jennifer King; Clivel Charlton
Journal: Neurochem Res Date: 2007-08-24 Impact factor: 3.996

Review 8. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors: Toshiharu Nagatsu; Ikuko Nagatsu
Journal: J Neural Transm (Vienna) Date: 2016-08-04 Impact factor: 3.575

9. Effect of duration of levodopa/decarboxylase inhibitor therapy on the pharmacokinetic handling of levodopa in elderly patients with idiopathic Parkinson's disease.

Authors: S G Bowes; C J O'Neill; P W Nicholson; A L Leeman; A A Deshmukh; R J Dobbs; S M Dobbs
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

10. Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Authors: J Dingemanse; K Jorga; G Zürcher; M Schmitt; G Sedek; M Da Prada; P Van Brummelen
Journal: Br J Clin Pharmacol Date: 1995-09 Impact factor: 4.335